CD79B and diffuse large B-cell lymphoma: Recurrent mutations affecting the ITAM motifs of CD79B and CD79A (frequently seen in the activated B cell subtype [ABC subtype] of diffuse large B cell lymphoma) potentiate BCR signaling (19, 20).